Literature DB >> 20351678

Advances in hematology. Etiology and diagnosis of acquired von Willebrand syndrome.

Massimo Franchini1, Giuseppe Lippi, Emmanuel J Favaloro.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20351678

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  7 in total

1.  Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management.

Authors:  Massimo Franchini; Giancarlo Castaman; Antonio Coppola; Cristina Santoro; Ezio Zanon; Giovanni Di Minno; Massimo Morfini; Elena Santagostino; Angiola Rocino
Journal:  Blood Transfus       Date:  2015-06-24       Impact factor: 3.443

Review 2.  Towards personalised therapy for von Willebrand disease: a future role for recombinant products.

Authors:  Emmanuel J Favaloro
Journal:  Blood Transfus       Date:  2016-03-22       Impact factor: 3.443

3.  Acquired Von Willebrand's Syndrome in Systemic Lupus Erythematosus.

Authors:  Sara Taveras Alam; Karenza Alexis; Ashwin Sridharan; Marianna Strakhan; Tarek Elrafei; Richard J Gralla; Louis J Reed
Journal:  Case Rep Hematol       Date:  2014-12-07

Review 4.  Acquired von Willebrand syndrome: focused for hematologists.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Haematologica       Date:  2020-06-18       Impact factor: 9.941

5.  Case report: A case of acquired von Willebrand syndrome as onset clinical presentation of systemic lupus erythematosus manifested as epistaxis and pulmonary hemorrhage.

Authors:  Songmi Wang; Qun Hu; Yaxian Chen; Xiufen Hu; Ning Tang; Ai Zhang; Aiguo Liu
Journal:  Front Pediatr       Date:  2022-09-20       Impact factor: 3.569

6.  von Willebrand's disease: a report from a meeting in the Åland islands.

Authors:  E Berntorp; I Peake; U Budde; M Laffan; R Montgomery; J Windyga; A Goodeve; P Petrini; M von Depka; W Miesbach; D Lillicrap; A B Federici; R Lassila; G White
Journal:  Haemophilia       Date:  2012-09       Impact factor: 4.287

7.  A Case of Acquired von Willebrand Disease Secondary to Myeloproliferative Neoplasm.

Authors:  Sreethish Sasi; Mohamed A Yassin; Afraa M Fadul
Journal:  Case Rep Oncol       Date:  2020-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.